Merck
CN
  • Quantitative imaging of a therapeutic peptide in biological tissue sections by MALDI MS.

Quantitative imaging of a therapeutic peptide in biological tissue sections by MALDI MS.

Bioanalysis (2013-02-22)
Nozomi Takai, Yukari Tanaka, Ayahisa Watanabe, Hideo Saji
ABSTRACT

Therapeutic peptides and proteins are being increasingly explored as potential therapeutic agents for molecular-targeted therapy, and the requirement for quantitative bioanalytical tools for such molecules has been discussed. The distribution of octreotide, a synthetic octapeptide analog of somatostatin, in the liver and kidney of mice administered with the analog was clearly visualized by MALDI-Imaging MS (IMS). The developed MALDI-IMS analytical method successfully quantified the amount of octreotide on tissue sections (accuracy was 76-127%) and the 2,5-dihydroxybenzoic acid-based normalization method was effective. The results of this study suggest that MALDI-IMS enables the quantification of an administered therapeutic peptide on biological tissue sections, as well as visualization of the in vivo distribution of the peptide.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Gentisic acid sodium salt hydrate, ≥98%
Supelco
2,5-Dihydroxybenzoic acid, matrix substance for MALDI-MS, ≥99.5% (HPLC), Ultra pure
Supelco
2,5-Dihydroxybenzoic acid, matrix substance for MALDI-MS, >99.0% (HPLC)
Sigma-Aldrich
2,5-Dihydroxybenzoic acid, 98%